Real-time enrollment status for this peripheral t cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 9:43 PM UTC
| NCT Number | NCT06072131 |
| Recruiting Status | Recruiting |
| Condition | Peripheral T Cell Lymphoma |
| Phase | PHASE3 |
| Target Enrollment | 504 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Acrotech Biopharma Inc. |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 31, 2026: Clinical trial NCT06072131 is currently recruiting participants. This phase3 study for peripheral t cell lymphoma is actively seeking new participants at 11 locations across the United States. The study is sponsored by Acrotech Biopharma Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06072131 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06072131 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.